Now through December 22nd receive 20% off plus FREE shipping on all print products at Tarascon.com.
The interactive version of the 2015 Tarascon Catalog is now available.
Topics: Catalog, discount, Global Health Blog, Hospital Medicine Blog, General Medicine, Infectious Disease, mobile medicine, oncology, Pharma, Pharmacopoeia, Physician, Prescribing, primary care, resource, Tarascon
The Tarascon Pharmacopoeia 2015 Editions continue the tradition as the leading pocket drug reference packed with vital drug information to help clinicians make better decisions at the point of care.
Topics: Cardiology, doctors, dosing, Global Health Blog, Hospital Medicine Blog, emergency medicine, General Medicine, hospital medicine, Infectious Disease, infectious disease, medicine, mobile medicine, oncology, Pharma, pharma, Pharmacopoeia, physicians, prescribe, prescribing, Prescribing, primary care, Pyschiatry & Mental Health, Tarascon
Swedish scientists from the Chalmers University of Technology, Sahlgrenska Academy, and Sahlgrenska University Hospital, have created a helmet that can quickly determine whether a patient has suffered a stroke and can determine if a clot or leaky vessel was the cause.
October marks the 14th anniversary of Health Literacy Month, a grassroots initiative founded by award-winning Jones & Bartlett Learning author, Helen Osborne, to raise awareness about the need for more easily understandable health communication. This year’s theme is “Be a Health Literacy Hero.”
Jones & Bartlett is pleased to announce the launch of the Jones & Bartlett Learning Author’s Corner, a resource for prospective and new authors. The site contains the most up-to-date, general information on art development, manuscript submission, the publishing process, and editorial contacts. It also houses pertinent documents including: author information forms, marketing questionnaires, and proposal guidelines.
Topics: allied health, Author, Cardiology, Contest, Global Health Blog, Hospital Medicine Blog, education, General Medicine, health, Infectious Disease, Authors, Jones & Bartlett, medicine, oncology, patient education, Prescribing, primary care, publication, Pyschiatry & Mental Health, text
February 28th will mark the sixth annual Rare Disease Day which is meant to raise awareness for rare diseases and improve access to treatment and medical representation for patients and their families. The first observance was on February 29th, 2008, and was chosen because it was a "rare day." In 2009, Rare Disease Day went global with participation from patient advocacy organizations in the United States, China, Australia, Taiwan, and Latin America. More than 60 countries and regions worldwide are now involved in planning awareness-raising activities.
Rare Disease Facts
- In the U.S., a rare disease typically affects a patient population estimated at fewer than 200,000
- There are more than 7,000 rare diseases affecting an estimated 30 million people in the U.S., and more than 300 million globally
- Almost 1 in 10 Americans is affected by a rare disease
- Approximately 80% of rare diseases are genetic
- The National Institutes of Health (NIH) estimates that 50% of the people affected by rare diseases are children
- While individual rare diseases have small patient populations, collectively the rare disease community is larger than the AIDS and Cancer communities combined
- Only 15% of rare diseases have organizations or foundations providing support or driving research
- An estimated 95% of all rare diseases do not have a single FDA approved drug treatment
The Global Genes Project
The Global Genes Project is a non-profit organization led by Team R.A.R.E and R.A.R.E. Project, and aims to raise awareness for people and families touched by rare and genetic diseases. What began as a grassroots movement has now expanded into 500 organizations worldwide.
Topics: awareness, Global Health Blog, General Medicine, genetic disease, genetic disorder, global genes project, Global health, medical, national human genome research institute, National organization of rare disorders, NIH, patient education, patient education, rare disease day
After months of deliberation, a controversial study from the Netherlands examining how the H5N1 virus - also known as avian influenza or bird flu, could be genetically altered and transmitted by mammals as an airborne pathogen was published last week. The paper was completed in 2011, but because of widespread concerns that bioterrorists could use this information to engineer a weapon, the findings were not published until now.
Avian flu affects several types of birds, including farmed poultry (chickens, geese, turkeys and ducks). Bird flu can also be transmitted from livestock to wild birds and also to pet birds, and vice-versa. The virus spreads through infected birds, via their saliva, nasal secretions, feces, and feed.
The first avian influenza virus to infect humans occurred in Hong Kong in 1997 and was linked to infected chickens.
Human cases of H5N1 have since been reported in Asia, Africa, Europe, Indonesia, Vietnam, the Pacific, and the near East. Since 2003, nearly 60% of the 606 cases of human infection of H5N1 reported to the World Health Organization (WHO) worldwide, have resulted in death.
Topics: Anthony Fauci, avian flu, avian influenza, bird flu, Bruce Alberts, Center of Excellence for Influenza Research and Su, Global Health Blog, flu, Food and Drug Administration (FDA), H5N1, Infectious Disease, influenza, National Institute of Allergy and Infectious Disea, National Institute of Health, Netherlands, pandemic, Science journal, vaccine, virus, World Health Organization (WHO)
Topics: Africa, Botswana, Global Health Blog, Fogarty International Center, Global health, health workers, Authors, Matthew Dasco MD, Medical Education Partnership Initiative, MEPI, Ministry of Health, National Institute of Health (NIH), University of Botswana School of Medicine, US Health Resources and Services Organization